Table 4.
The difference of efficacy, according to LDH—elevated LDH at baseline, 16 and 32 weeks showed inadequate treatment response in EASI.
LDH at baseline | LDH at 16 weeks | LDH at 32 weeks | LDH at 52 weeks | |||||
---|---|---|---|---|---|---|---|---|
< 250 (n = 30) | ≥ 250 (n = 43) | < 250 (n = 66) | ≥ 250 (n = 22) | < 250 (n = 63) | ≥ 250 (n = 21) | < 250 (n = 65) | ≥ 250 (n = 6) | |
Percent change of EASI after 52 weeks | 90.50 | 85.55 | 89.42 | 84.49 | 90.75 | 82.49 | 89.32 | 78.60 |
p value* | 0.014 | 0.046 | < 0.001 | 0.052 | ||||
Percent change of NRS after 52 weeks | 70.29 | 62.63 | 68.36 | 57.69 | 70.46 | 59.37 | 69.18 | 47.22 |
p value* | 0.194 | 0.067 | 0.052 | 0.003 | ||||
Percent change of POEM after 52 weeks | 67.62 | 66.85 | 68.76 | 67.10 | 71.22 | 68.06 | 70.87 | 36.13 |
p value* | 0.920 | 0.793 | 0.576 | < 0.001 | ||||
Percent change of DLQI after 52 weeks | 72.78 | 65.38 | 70.22 | 63.33 | 74.16 | 61.82 | 73.49 | 46.98 |
p value* | 0.315 | 0.260 | 0.058 | 0.013 |
*p values were obtained by two sample independent t-test.